// App-Quantinova.ai

: - First results of the AMYPAD Prognostic and Natural History Study: amyloid-PET Centiloid predicts cognitive functioning in a pre-dementia population

Researchers

Presenter

  • David Vállez García

Principal Investigators

  • Sophie E Mastenbroek

  • Isadora Lopes Alves

  • Juan Domingo Gispert

  • Craig W. Ritchie

  • Mercè Boada

  • Marta Marquié

  • Oriol Grau-Rivera

  • Karine Fauria

  • Philip Scheltens

  • Rik Vandenberghe

  • Bernard J Hanseeuw

  • Michael Schöll

  • Giovanni B Frisoni

  • Henning Boecker

  • Frank Jessen

  • Robin Wolz

  • Sylke Grootoonk

  • Andrew W Stephens

  • Chris J Buckley

  • Lisa Ford

  • Pieter Jelle Visser

  • Gill Farrar

  • Frederik Barkhof

Medical Centers

  • Cooper University Hospital,

  • Amsterdam UMC, location VUmc

  • University of Edinburgh,

  • University Hospital of Berne,

  • Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • IXICO

  • Janssen Research and Development, PA.

  • CERVO Brain research centre

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, De Boelelaan 1117

  • GE Healthcare

  • GE Healthcare Pharmaceutical Diagnostics

  • Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation

  • German Center for Neurodegenarative Diseases (DZNE)

  • Life Molecular Imaging

  • University of Gothenburg,

  • KULeuven

  • Alzheimer Center Amsterdam, Amsterdam UMC

  • Université Catholique de Louvain, Belgium

  • Fundació ACE. Barcelona Alzheimer Treatment & Research Center

Locations

  • United Kingdom

  • United States

  • Venezuela

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Dementia

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved